BACKGROUND: Maintaining vitamin D sufficiency may decrease the incidence of pulmonary tuberculosis and other infectious diseases. We present the first prospective study of vitamin D among human immunodeficiency virus (HIV)-infected adults receiving antiretrovirals in sub-Saharan Africa. METHODS: Serum 25-hydroxyvitamin D (25(OH)D) level was assessed at antiretroviral therapy (ART) initiation for 1103 HIV-infected adults enrolled in a trial of multivitamins (not including vitamin D) in Tanzania. Participants were prospectively followed at monthly visits at which trained physicians performed a clinical examination and nurses took anthropometric measurements and assessed self-reported symptoms. Cox proportional hazards models estimated hazard ratios (HRs) of morbidity outcomes. RESULTS: After multivariate adjustment, vitamin D deficiency (defined as a concentration of <20 ng/mL) had a significantly greater association with incident pulmonary tuberculosis, compared with vitamin D sufficiency (HR, 2.89; 95% confidence interval [CI], 1.31-7.41; P = .027), but no association was found for vitamin D insufficiency (defined as a concentration of 20-30 ng/mL; P = .687). Deficiency was also significantly associated with incident oral thrush (HR, 1.96; 95% CI, 1.01-3.81; P = .046), wasting (HR, 3.10; 95% CI, 1.33-7.24; P = .009), and >10% weight loss (HR, 2.10; 95% CI, 1.13-3.91; P = .019). Wasting results were robust to exclusion of individuals experiencing pulmonary tuberculosis. Vitamin D status was not associated with incident malaria, pneumonia, or anemia. CONCLUSIONS: Vitamin D supplementation trials for adults receiving ART appear to be warranted.
BACKGROUND: Maintaining vitamin D sufficiency may decrease the incidence of pulmonary tuberculosis and other infectious diseases. We present the first prospective study of vitamin D among human immunodeficiency virus (HIV)-infected adults receiving antiretrovirals in sub-Saharan Africa. METHODS: Serum 25-hydroxyvitamin D (25(OH)D) level was assessed at antiretroviral therapy (ART) initiation for 1103 HIV-infected adults enrolled in a trial of multivitamins (not including vitamin D) in Tanzania. Participants were prospectively followed at monthly visits at which trained physicians performed a clinical examination and nurses took anthropometric measurements and assessed self-reported symptoms. Cox proportional hazards models estimated hazard ratios (HRs) of morbidity outcomes. RESULTS: After multivariate adjustment, vitamin Ddeficiency (defined as a concentration of <20 ng/mL) had a significantly greater association with incident pulmonary tuberculosis, compared with vitamin D sufficiency (HR, 2.89; 95% confidence interval [CI], 1.31-7.41; P = .027), but no association was found for vitamin Dinsufficiency (defined as a concentration of 20-30 ng/mL; P = .687). Deficiency was also significantly associated with incident oral thrush (HR, 1.96; 95% CI, 1.01-3.81; P = .046), wasting (HR, 3.10; 95% CI, 1.33-7.24; P = .009), and >10% weight loss (HR, 2.10; 95% CI, 1.13-3.91; P = .019). Wasting results were robust to exclusion of individuals experiencing pulmonary tuberculosis. Vitamin D status was not associated with incident malaria, pneumonia, or anemia. CONCLUSIONS:Vitamin D supplementation trials for adults receiving ART appear to be warranted.
Authors: R J Wilkinson; M Llewelyn; Z Toossi; P Patel; G Pasvol; A Lalvani; D Wright; M Latif; R N Davidson Journal: Lancet Date: 2000-02-19 Impact factor: 79.321
Authors: Mario Fabri; Steffen Stenger; Dong-Min Shin; Jae-Min Yuk; Philip T Liu; Susan Realegeno; Hye-Mi Lee; Stephan R Krutzik; Mirjam Schenk; Peter A Sieling; Rosane Teles; Dennis Montoya; Shankar S Iyer; Heiko Bruns; David M Lewinsohn; Bruce W Hollis; Martin Hewison; John S Adams; Andreas Steinmeyer; Ulrich Zügel; Genhong Cheng; Eun-Kyeong Jo; Barry R Bloom; Robert L Modlin Journal: Sci Transl Med Date: 2011-10-12 Impact factor: 17.956
Authors: J Andersson; T E Fehniger; B K Patterson; J Pottage; M Agnoli; P Jones; H Behbahani; A Landay Journal: AIDS Date: 1998-07-30 Impact factor: 4.177
Authors: G Nunnari; P Fagone; F Lazzara; A Longo; D Cambria; G Di Stefano; M Palumbo; L Malaguarnera; Michelino Di Rosa Journal: Mol Cell Biochem Date: 2016-06-13 Impact factor: 3.396
Authors: Christopher R Sudfeld; Ferdinand Mugusi; Alfa Muhihi; Said Aboud; Tumaini J Nagu; Nzovu Ulenga; Biling Hong; Molin Wang; Wafaie W Fawzi Journal: Lancet HIV Date: 2020-07 Impact factor: 12.767
Authors: Fiona Havers; Laura Smeaton; Nikhil Gupte; Barbara Detrick; Robert C Bollinger; James Hakim; Nagalingeswaran Kumarasamy; Adriana Andrade; Parul Christian; Javier R Lama; Thomas B Campbell; Amita Gupta Journal: J Infect Dis Date: 2014-05-05 Impact factor: 5.226
Authors: Ramadhani A Noor; Ajibola I Abioye; Ellen Hertzmark; Anne M Darling; Said Aboud; Ferdinand M Mugusi; Christopher R Sudfeld; Donna Spiegelman; Wafaie W Fawzi Journal: J Nutr Date: 2020-09-01 Impact factor: 4.798
Authors: Christopher R Sudfeld; Christopher Duggan; Said Aboud; Roland Kupka; Karim P Manji; Rodrick Kisenge; Wafaie W Fawzi Journal: J Nutr Date: 2014-11-12 Impact factor: 4.798
Authors: Panagiotis Dragonas; Linda M Kaste; Martha Nunn; Praveen K Gajendrareddy; Kathleen M Weber; Mardge Cohen; Oluwatoyin M Adeyemi; Audrey L French; Herve Y Sroussi Journal: Oral Surg Oral Med Oral Pathol Oral Radiol Date: 2018-02-19